Quest Diagnostics Inc. and Pathai Inc. established a forward-looking deal with multiple components and room for growth. The ...

Novartis AG is bolstering its radioligand arsenal with the takeout of Mariana Oncology Inc. for $1 billion up front and as ...

Japanese researchers have transplanted human induced pluripotent stem cells (iPSCs) in a primate model of myocardial infarction and were able to restore heart muscle and function in monkeys. Developed ...

Medtronic plc said it secured U.S. FDA approval for its first closed-loop spinal cord stimulator (SCS), designed to take in ...

Hologic Inc. moved to expand its breast surgery line with the acquisition of Endomagnetics Ltd. (Endomag) for a proposed $310 ...

Novartis Pharma AG continues to build up its radiopharmaceutical powerhouse and has expanded a peptide discovery ...

Epitel Inc. received U.S. FDA clearances for two epilepsy-focused technologies that simplify detection and analysis of ...

Despite a couple of med-tech deals transacted this year and more liquidity in the market, early-stage medical device ...

In what represents its first patenting, PBSF Inc. filed for protection of brain monitoring and neuroprotection strategies for ...

Royal Philips NV has come to terms over class-action litigation in which plaintiffs alleged that particulate matter in ...

As Poseida Therapeutics Inc. anticipates reporting further data this year from allogeneic CAR T-cell therapy P-MUC1C-ALLO1, for which Astellas Pharma Inc. has nabbed first negotiation rights, the two ...

U.S. Medicare coverage of products for leg and foot ulcers has undergone a second review in less than a year thanks to ...